US EditionAbbVie (NYSE:ABBV) Stock Price Down 1.9% – Time to Sell?
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
AbbVie (NYSE:ABBV) Stock Price Down 1.9% – Time to Sell?
AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price fell 1.9% during trading on Monday . The company traded as low as $176.28 and last traded at $183.42. 3,740,407 shares traded hands during mid-day trading, a decline of 35% from the average session volume of 5,768,494 shares. The stock had previously closed at $186.96. Wall […]
Krane Funds Advisors LLC Trims Stake in AbbVie Inc. (NYSE:ABBV)
Krane Funds Advisors LLC cut its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 8.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,997 shares of the company’s stock after selling 185 shares during the period. Krane Funds […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
